Drawing for DRUGHUNTERS

USPTO serial 79268286

DRUGHUNTERS

Reviewed by CopyMark Law Group

Status 601
Filing date
Status date
Registration date
—
Examiner
MONINGHOFF, KIM TERESA
Law office
TMO LAW OFFICE 113 - EXAMINING ATTORNEY ASSIGNED

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with DRUGHUNTERS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Claudia A. Smith

Claudia A. Smith WHITE & CASE LLP1221 Avenue of the AmericasTrademark DepartmentNEW YORK, NY 10020

Goods and services

ClassDescriptionStatusFirst use
041Education; providing of training; entertainment; organization and carrying out of congresses, seminars, courses, events, competitions and symposia within the field of medicine and pharmaceuticals; organizing and arranging competitions and educational competitions: on-line training programs, webinars; arranging and conducting of expert forums, including on-line, in the form of webinars, seminars, conferences, symposia, workshops (education) and courses; arranging and conducting of expert forums, including on-line, in the field of research and development, science, clinical tests and trials, diagnostic, medicine, pharmaceuticals, disorders, diseases, treatment and prevention; educational and training services in the field of research and development, science, clinical tests and trials, diagnostic, medicine, pharmaceuticals, disorders, diseases, treatment and prevention provided electronically, on-line, via cable or Internet or other electronic media; providing on-line publications (not downloadable), including of books, reports, brochures, booklets, event programmes, leaflets, patient information leaflets, magazines, journals, teaching and educational material in the field of research and development, science, clinical tests and trials, diagnostic, medicine, pharmaceuticals, disorders, diseases, treatment and prevention; educational and entertainment services in the nature of providing non-downloadable videos and images featuring health and medicine content via the Internet; educational and entertainment services in the nature of providing non-downloadable videos and images featuring health and medicine content through a website, social media platforms and appsACTIVE—
042Pharmaceutical research and development; scientific and technological services and research and design related thereto related to the central nervous system and central nervous system related disorders and diseases and pharmaceuticals; medical research and tests; clinical research and tests; diagnostic research and tests; providing on-line non-downloadable screening tools (software) for assessment of cognitive functions and of psychiatric and neurological disorders and diseases; providing online non-downloadable screening tools (software) for diagnosing, managing, monitoring, assessing, controlling and examining psychiatric and neurological disorders and diseasesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 30, 2021FINTFINAL DECISION TRANSACTION PROCESSED BY IB—
May 11, 2021FICSFINAL DISPOSITION NOTICE SENT TO IB—
May 11, 2021FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Mar 20, 2021OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Mar 3, 2021OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Mar 3, 2021OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
May 11, 2020MAB1ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT—
May 11, 2020ABN1ABANDONMENT - EXPRESS MAILED—
May 8, 2020EXARTEAS EXPRESS ABANDONMENT RECEIVED—
Apr 30, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Apr 30, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 30, 2020ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Apr 30, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 30, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 30, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Nov 16, 2019RFNTREFUSAL PROCESSED BY IB—
Oct 31, 2019RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Oct 31, 2019RFRRREFUSAL PROCESSED BY MPU—
Oct 10, 2019RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Oct 9, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 8, 2019MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 3, 2019DOCKASSIGNED TO EXAMINER—
Oct 3, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 27, 2019LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Sep 26, 2019REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance